Abstract
Radiofrequency ablation (RFA) provides favorable local efficacy in the treatment of small hepatocellular carcinoma. Thus, this modality has been applied to other types of cancer such as metastatic cancer to the liver and the lung. Herein, we focus on RFA for such metastatic cancer and introduce its clinical outcomes. Such outcomes may suggest the potential to offer long-term survival for the patients with oligo-recurrence or oligometastasis. Notable advantages of RFA include its low invasiveness, the preservation of organ function, the freedom to perform the procedure regardless of any previous therapy, and the ability to repeat the procedure whenever required.
| Original language | English |
|---|---|
| Pages (from-to) | 1069-1075 |
| Number of pages | 7 |
| Journal | Japanese Journal of Clinical Radiology |
| Volume | 58 |
| Issue number | 8 |
| Publication status | Published - Aug 2013 |
Fingerprint
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Cite this
Application of RFA for the treatment of oligometastasis and oligo-recurrence. / Hiraki, Takao.
In: Japanese Journal of Clinical Radiology, Vol. 58, No. 8, 08.2013, p. 1069-1075.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Application of RFA for the treatment of oligometastasis and oligo-recurrence
AU - Hiraki, Takao
PY - 2013/8
Y1 - 2013/8
N2 - Radiofrequency ablation (RFA) provides favorable local efficacy in the treatment of small hepatocellular carcinoma. Thus, this modality has been applied to other types of cancer such as metastatic cancer to the liver and the lung. Herein, we focus on RFA for such metastatic cancer and introduce its clinical outcomes. Such outcomes may suggest the potential to offer long-term survival for the patients with oligo-recurrence or oligometastasis. Notable advantages of RFA include its low invasiveness, the preservation of organ function, the freedom to perform the procedure regardless of any previous therapy, and the ability to repeat the procedure whenever required.
AB - Radiofrequency ablation (RFA) provides favorable local efficacy in the treatment of small hepatocellular carcinoma. Thus, this modality has been applied to other types of cancer such as metastatic cancer to the liver and the lung. Herein, we focus on RFA for such metastatic cancer and introduce its clinical outcomes. Such outcomes may suggest the potential to offer long-term survival for the patients with oligo-recurrence or oligometastasis. Notable advantages of RFA include its low invasiveness, the preservation of organ function, the freedom to perform the procedure regardless of any previous therapy, and the ability to repeat the procedure whenever required.
UR - http://www.scopus.com/inward/record.url?scp=84883027785&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883027785&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84883027785
VL - 58
SP - 1069
EP - 1075
JO - Japanese Journal of Clinical Radiology
JF - Japanese Journal of Clinical Radiology
SN - 0009-9252
IS - 8
ER -